EMS provider Qisda will set up a joint venture in China, BenQ Biotech (Shanghai), with China-based Shanghai Kunxin Medical Technology to produce hemodialyzers for sale in the Chinese market, with Qisda to invest CNY240 million ($33.7 million) for a 70% stake.
Qisda's subsidiary BenQ Dialysis Technology has developed hemodialyzers for in-house production and own-brand sale, and obtained certification and a marketing license from South Korea's Ministry of Food and Drug Safety in August 2018, with marketing there beginning in fourth-quarter 2018.